Scott Nathan Compton

Scott Nathan Compton

Associate Professor in Psychiatry and Behavioral Sciences

Education & Training

  • Ph.D., University of Nevada at Reno 1998

Expertise

Anxiety disorders, cognitive-behavioral therapy, children and adolescents, trichotillomania

Pistorello, Jacqueline, et al. “A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality (CAMS) Versus Treatment as Usual (TAU) for Suicidal College Students.Arch Suicide Res, Apr. 2020, pp. 1–25. Pubmed, doi:10.1080/13811118.2020.1749742. Full Text

Kagan, Elana R., et al. “Antidepressant Use in a 3- to 12-Year Follow-up of Anxious Youth: Results from the CAMELS Trial.Child Psychiatry Hum Dev, Apr. 2020. Pubmed, doi:10.1007/s10578-020-00983-w. Full Text

O’Rourke, Sarah R., et al. “The Emotional and Behavioral Impact of Delivering Bad News to Virtual versus Real Standardized Patients: A Pilot Study.Teach Learn Med, vol. 32, no. 2, Apr. 2020, pp. 139–49. Pubmed, doi:10.1080/10401334.2019.1652180. Full Text

Cervin, Matti, et al. “Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders.J Child Psychol Psychiatry, vol. 61, no. 4, Apr. 2020, pp. 492–502. Pubmed, doi:10.1111/jcpp.13124. Full Text

Wu, Monica S., et al. “The Impact of Treatment Expectations on Exposure Process and Treatment Outcome in Childhood Anxiety Disorders.J Abnorm Child Psychol, vol. 48, no. 1, Jan. 2020, pp. 79–89. Pubmed, doi:10.1007/s10802-019-00574-x. Full Text

Bai, Sunhye, et al. “Longitudinal Study of Sleep and Internalizing Problems in Youth Treated for Pediatric Anxiety Disorders.J Abnorm Child Psychol, vol. 48, no. 1, Jan. 2020, pp. 67–77. Pubmed, doi:10.1007/s10802-019-00582-x. Full Text

Norris, Lesley A., et al. “Multi-informant Expectancies and Treatment Outcomes for Anxiety in Youth.Child Psychiatry Hum Dev, vol. 50, no. 6, Dec. 2019, pp. 1002–10. Pubmed, doi:10.1007/s10578-019-00900-w. Full Text

Sanchez, Amanda L., et al. “The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination.Child Psychiatry Hum Dev, vol. 50, no. 6, Dec. 2019, pp. 940–49. Pubmed, doi:10.1007/s10578-019-00896-3. Full Text

Babiano-Espinosa, Lucía, et al. “Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review.Syst Rev, vol. 8, no. 1, Nov. 2019, p. 284. Pubmed, doi:10.1186/s13643-019-1166-6. Full Text

Jensen, Sanne, et al. “Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment.J Child Psychol Psychiatry, Nov. 2019. Pubmed, doi:10.1111/jcpp.13155. Full Text

Pages

Compton, S. N., et al. “Introduction.” Pediatric Anxiety Disorders, 2019, pp. 3–5. Scopus, doi:10.1016/B978-0-12-813004-9.00001-3. Full Text

Villabø, M. A., and S. N. Compton. “Cognitive behavioral therapy.” Pediatric Anxiety Disorders, 2019, pp. 317–34. Scopus, doi:10.1016/B978-0-12-813004-9.00015-3. Full Text

Burns, B. J., et al. “An Annotated Bibliography of Evidence for Diagnostic-Specific Psychosocial and Psychopharmacological Interventions.” Community Treatment for Youth: Evidence-Based Interventions for Severe Emotional and Behavioral Disorders, 2009. Scopus, doi:10.1093/acprof:oso/9780195134575.003.0011. Full Text

Compton, S. N., et al. Pediatric anxiety disorders. 2019, pp. 1–551. Scopus, doi:10.1016/C2016-0-04425-X. Full Text

Bushnell, Greta A., et al. “Initial Prescription Medication for Children with Anxiety: Concordance with Evidence.” Pharmacoepidemiology and Drug Safety, vol. 24, WILEY-BLACKWELL, 2015, pp. 283–84.

Selected Grants

Novel Approaches to Infant Screening for ASD in Pediatric Primary Care awarded by National Institutes of Health (Co Investigator). 2019 to 2024

2/4 Adapting Treatments for Suicidal College Students: A Multisite Trial awarded by National Institutes of Health (Principal Investigator). 2019 to 2023

Marcus Foundation Phase II MSC ASD awarded by (Data Manager). 2019 to 2022

NBI-98854 Follow up awarded by (Principal Investigator). 2018 to 2020

Evaluating the impact of an emotion regulation intervention on emotion perception awarded by National Institutes of Health (Collaborator). 2018 to 2020

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled awarded by (Principal Investigator). 2018 to 2019

Duke: 3/5-The Autism Biomarkers Consortium DAAC awarded by Yale University (Data Analyst). 2015 to 2018

Evaluating a Novel Method of Generalizing Emotion Regulation awarded by National Institutes of Health (Co Investigator). 2012 to 2017

Pages